# Hemab Therapeutics Holdings, Inc.: filings

COAG · Nasdaq · CIK 2114044 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/coag.md) · [Financials](/companies/coag/financials.md) · [Filings](/companies/coag/filings.md) · [Insiders](/companies/coag/insiders.md)

## Reports and events: 12 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 12, 4 10, SCHEDULE 13G 8, 8-K 5, S-1/A 3, 10-Q 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, EFFECT 1, S-1 1, S-1MEF 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-24 | 16:03 ET | [8-K](/filings/0001193125-26-401010.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-401010 |
| 2026-08-11 | 16:00 ET | [10-Q](/filings/0001193125-26-344533.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344533 |
| 2026-08-11 | 07:11 ET | [8-K](/filings/0001193125-26-343421.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343421 |
| 2026-05-21 | 16:02 ET | [10-Q](/filings/0001193125-26-234386.md) | Quarterly report, period 2026-03-31 | 0001193125-26-234386 |
| 2026-05-21 | 07:05 ET | [8-K](/filings/0001193125-26-233375.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-233375 |
| 2026-05-11 | 16:43 ET | [SCHEDULE 13D](/filings/0001193125-26-216973.md) | Ownership report, active investor | 0001193125-26-216973 |
| 2026-05-11 | 16:01 ET | [8-K](/filings/0001193125-26-216699.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-216699 |
| 2026-05-04 | 16:09 ET | [8-K](/filings/0001193125-26-203988.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-203988 |
| 2026-04-30 | 06:39 ET | [S-1/A](/filings/0001193125-26-193885.md) | Registration statement, amended | 0001193125-26-193885 |
| 2026-04-28 | 16:08 ET | [S-1/A](/filings/0001193125-26-186964.md) | Registration statement, amended | 0001193125-26-186964 |
| 2026-04-27 | 07:09 ET | [S-1/A](/filings/0001193125-26-178809.md) | Registration statement, amended | 0001193125-26-178809 |
| 2026-04-10 | 16:41 ET | [S-1](/filings/0001193125-26-151378.md) | Registration statement | 0001193125-26-151378 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.